[1] Fock KM, Talley N, Moayyedi P, Hunt R, Azuma T, Su-gano K, Xiao SD, Lam SK, Goh KL, Chiba T, Uemura N, Kim JG, Kim N, Ang TL, Mahachai V, Mitchell H, Rani AA, Liou JM, Vilaichone RK, Sollano J. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gas-troenterol Hepatol, 2008, 23(3): 351-365.
[2] Snaith A, El-Omar EM. Helicobacter pylori: host genetics and disease outcomes. Exp Rev Gastroenterol Hepatol, 2008, 2(4): 577-585.
[3] Mooney SD, Krishnan VG, Evani US. Bioinformatic tools for identifying disease gene and SNP candidates. Methods Mol Biol, 2010, 628: 307-319.
[4] Hamajima N, Naito M, Kondo T, Goto Y. Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci, 2006, 97(11): 1129-1138.
[5] Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Hi-rooka Y, Niwa Y, Goto H. Interleukin-8 promoter poly-morphism increases the risk of atrophic gastritis and gas-tric cancer in Japan. Cancer Epidemiol Biomarkers Prev, 2005, 14(11 Pt 1): 2487-2493.
[6] Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, Koike T, Sekine H, Ohara S, Shimosegawa T. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut, 2005, 54(3): 330-335.
[7] Lu WL, Pan KF, Zhang L, Lin DX, Miao XP, You WC. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis, 2005, 26(3): 631-636.
[8] Savage SA, Hou L, Lissowska J, Chow WH, Zatonski W, Chanock SJ, Yeager M. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev, 2006, 15(3): 589-591.
[9] Canedo P, Castanheira-Vale AJ, Lunet N, Pereira F, Figueiredo C, Gioia-Patricola L, Canzian F, Moreira H, Suriano G, Barros H, Carneiro F, Seruca R, Machado JC. The interleukin-8-251*T/*A polymorphism is not associ-ated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev, 2008, 17(1): 28-32.
[10] Ma SL, Tang NL, Lam LC, Chiu HF. The association be-tween promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging, 2005, 26(7): 1005-1010.
[11] El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH. Increased risk of noncardia gastric cancer associated with proin-flammatory cytokine gene polymorphisms. Gastroen-terology, 2003, 124(5): 1193-1201.
[12] Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, Greco E, Gallo N, Rugge M, Di Mario F, Plebani M. Pro- and anti-inflammatory cytokines gene polymor-phisms and Helicobacter pylori infection: interactions in-fluence outcome. Cytokine, 2005 29(4): 141-152.
[13] Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut, 2004, 53(8): 1082-1089.
[14] Bai XL, Sun LP, Liu J, Chen W, Zhang Y, Yuan Y. Corre-lation of interleukin-10-1082G/a single nucleotide poly-morphism to the risk of gastric cancer in north China: a case-control study. Chinese Journal of Cancer, 2008, 27(1): 35-40.
[15] Sugimoto M, Furuta T, Shirai N, Nakamura A, Kajimura M, Sugimura H, Hishida A. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol, 2007, 22(9): 1443-1449.
[16] Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, Park JY, Lee JH, Kim JH, Yoo JY. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett, 2005, 225(2): 207-214.
[17] Achyut BR, Ghoshal UC, Moorchun
